e-learning
resources
Madrid 2019
Monday, 30.09.2019
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of nontuberculous mycobacterial pulmonary diseases (slow-growing organisms): an interactive session
C. Daley (Denver, United States of America)
Source:
International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Session:
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Session type:
Guidelines session
Number:
3243
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Daley (Denver, United States of America). Treatment of nontuberculous mycobacterial pulmonary diseases (slow-growing organisms): an interactive session. International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment of nontuberculous mycobacterial pulmonary diseases (fast-growing organisms): an interactive session
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Pulmonary non-tuberculous mycobacterial infection (pNTM) with multiple species
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021
Chronic infections, bronchiectasis and nontuberculous mycobacteria
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Surgery in nontuberculous mycobacteria pulmonary disease
Source: Breathe, 14 (4) 288; 10.1183/20734735.027218
Year: 2018
Management of nontuberculous mycobacterial infections
Source: International Congress 2015 – ME9 Management of non-tuberculous mycobacterial (NTM) infections
Year: 2015
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients
Source: Eur Respir J 2006; 28: 1211-1215
Year: 2006
Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease
Source: Eur Respir Monogr 2018; 81: 204-221
Year: 2018
Evaluation of the airway microbiome in nontuberculous mycobacteria disease
Source: Eur Respir J, 52 (4) 1800810; 10.1183/13993003.00810-2018
Year: 2018
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006
Nontuberculous mycobacterial pulmonary infections
Source: Eur Respir Monogr 2014; 66: 128-137
Year: 2014
Non-tuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept